Ori has developed a proprietary, flexible manufacturing platform that closes, automates, and standardizes CGT manufacturing allowing therapeutics developers to bring products to market at commercial scale. The promise of the full stack Ori platform is to fully automate CGT manufacturing to increase throughput, improve quality, and decrease costs by combining hardware, software, and data services, enabling broader access to these lifesaving treatments.
More on: chemicalsknowledgehub.com
Watch full interview: www.youtube.com/watch?v=T1UW0E-0ot0